查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411496

近距離放射治療市場：按適應症、產品、給藥類型、最終用戶分類 - 2024-2030 年全球預測

Brachytherapy Market by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer), Offering (Devices, Services), Dosage Type, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年近距離放射治療市場規模為9.6201億美元，2024年將達到10.1287億美元，2030年將達到14.2357億美元，複合年成長率為5.75%。

全球近距離放射治療市場

主要市場統計
基準年[2023] 96201萬美元
預測年份 [2024] 1,012,870,000 美元
預測年份 [2030] 1,423.57 百萬美元
複合年成長率（%） 5.75%
近距離放射治療市場-IMG1

FPNV定位矩陣

FPNV定位矩陣對於評估近距離放射治療市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對近距離放射治療市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-近距離放射治療市場的市場規模與預測是多少？

2-近距離放射治療市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-近距離治療市場的技術趨勢和法律規範是什麼？

4-近距離放射治療市場主要供應商的市場佔有率為何？

5-進入近距離治療市場的適當型態和策略性手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球癌症盛行率不斷上升，需要有效的治療
      • 疾病的早​​期診斷和治療趨勢
      • 對微創醫療程序的偏好日益增加
    • 抑制因素
      • 近距離放射治療高成本且複雜
    • 機會
      • 使用個人化醫療進行精準治療
      • 持續研究和開發以提高近距離放射治療的有效性
    • 任務
      • 嚴格的法律規範和缺乏熟練的專業人員
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章近距離放射治療市場（依適應症）

  • 乳癌
  • 婦科癌症
  • 攝護腺癌

第7章近距離放射治療市場：透過提供

  • 裝置
    • 後荷機
    • 施用器
    • 種子
  • 服務

第8章按給藥類型分類的近距離放射治療市場

  • 高劑量率 (HDR) 近距離放射治療
  • 低劑量率 (LDR) 近距離放射治療

第 9 章近距離放射治療市場：依最終用戶分類

  • 醫院
  • 專科診所

第10章美洲近距離放射治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區近距離放射治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲近距離放射治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第14章競爭產品組合

  • 主要公司簡介
    • Accuray Incorporated
    • BEBIG Medical GmbH
    • Becton, Dickinson and Company
    • Best Medical International, Inc.
    • BWX Technologies. Inc.
    • CivaTech Oncology Inc.
    • CIVCO Medical Solutions
    • Eckert & Ziegler Radiopharma GmbH
    • Elekta AB
    • GammaTile
    • Healvita Group GmbH
    • Hologic, Inc.
    • iCAD, Inc.
    • IsoAid, LLC
    • Isoray Medical, Inc. by Perspective Therapeutics
    • Mick Radio-Nuclear Instruments, Inc.
    • Mirion Technologies, Inc.
    • Nihon Medi-Physics Co., Ltd.
    • Qfix
    • Theragenics
    • Varian Medical Systems, Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-521BAA36EB68

[184 Pages Report] The Brachytherapy Market size was estimated at USD 962.01 million in 2023 and expected to reach USD 1,012.87 million in 2024, at a CAGR 5.75% to reach USD 1,423.57 million by 2030.

Global Brachytherapy Market

KEY MARKET STATISTICS
Base Year [2023] USD 962.01 million
Estimated Year [2024] USD 1,012.87 million
Forecast Year [2030] USD 1,423.57 million
CAGR (%) 5.75%
Brachytherapy Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brachytherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brachytherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brachytherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, BEBIG Medical GmbH, Becton, Dickinson and Company, Best Medical International, Inc., BWX Technologies. Inc., CivaTech Oncology Inc., CIVCO Medical Solutions, Eckert & Ziegler Radiopharma GmbH, Elekta AB, GammaTile, Healvita Group GmbH, Hologic, Inc., iCAD, Inc., IsoAid, LLC, Isoray Medical, Inc. by Perspective Therapeutics, Mick Radio-Nuclear Instruments, Inc., Mirion Technologies, Inc., Nihon Medi-Physics Co., Ltd., Qfix, Theragenics, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brachytherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Breast Cancer
    • Gynecological Cancer
    • Prostate Cancer
  • Offering
    • Devices
      • Afterloaders
      • Applicators
      • Seeds
    • Services
  • Dosage Type
    • High-Dose Rate (HDR) Brachytherapy
    • Low-Dose Rate (LDR) Brachytherapy
  • End User
    • Hospitals
    • Specialty Clinic
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brachytherapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brachytherapy Market?

3. What are the technology trends and regulatory frameworks in the Brachytherapy Market?

4. What is the market share of the leading vendors in the Brachytherapy Market?

5. Which modes and strategic moves are suitable for entering the Brachytherapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Brachytherapy Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cancer worldwide and need for efficient treatment
      • 5.1.1.2. Inclination toward early diagnosis and treatment of diseases
      • 5.1.1.3. Increasing preference for minimally invasive medical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and complexity in brachytherapy
    • 5.1.3. Opportunities
      • 5.1.3.1. Utilization of personalized medicine approach to deliver precise treatment
      • 5.1.3.2. Ongoing R&D to enhance the efficacy of brachytherapy
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory framework and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Brachytherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gynecological Cancer
  • 6.4. Prostate Cancer

7. Brachytherapy Market, by Offering

  • 7.1. Introduction
  • 7.2. Devices
    • 7.3.1. Afterloaders
    • 7.3.2. Applicators
    • 7.3.3. Seeds
  • 7.3. Services

8. Brachytherapy Market, by Dosage Type

  • 8.1. Introduction
  • 8.2. High-Dose Rate (HDR) Brachytherapy
  • 8.3. Low-Dose Rate (LDR) Brachytherapy

9. Brachytherapy Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinic

10. Americas Brachytherapy Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Brachytherapy Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Brachytherapy Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Accuray Incorporated
    • 14.1.2. BEBIG Medical GmbH
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Best Medical International, Inc.
    • 14.1.5. BWX Technologies. Inc.
    • 14.1.6. CivaTech Oncology Inc.
    • 14.1.7. CIVCO Medical Solutions
    • 14.1.8. Eckert & Ziegler Radiopharma GmbH
    • 14.1.9. Elekta AB
    • 14.1.10. GammaTile
    • 14.1.11. Healvita Group GmbH
    • 14.1.12. Hologic, Inc.
    • 14.1.13. iCAD, Inc.
    • 14.1.14. IsoAid, LLC
    • 14.1.15. Isoray Medical, Inc. by Perspective Therapeutics
    • 14.1.16. Mick Radio-Nuclear Instruments, Inc.
    • 14.1.17. Mirion Technologies, Inc.
    • 14.1.18. Nihon Medi-Physics Co., Ltd.
    • 14.1.19. Qfix
    • 14.1.20. Theragenics
    • 14.1.21. Varian Medical Systems, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BRACHYTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. BRACHYTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BRACHYTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRACHYTHERAPY MARKET DYNAMICS
  • FIGURE 7. BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 10. BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2030 (%)
  • FIGURE 12. BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. BRACHYTHERAPY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BRACHYTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BRACHYTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRACHYTHERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 6. BRACHYTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BRACHYTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BRACHYTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 10. BRACHYTHERAPY MARKET SIZE, BY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. BRACHYTHERAPY MARKET SIZE, BY AFTERLOADERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BRACHYTHERAPY MARKET SIZE, BY APPLICATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BRACHYTHERAPY MARKET SIZE, BY SEEDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BRACHYTHERAPY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRACHYTHERAPY MARKET SIZE, BY HIGH-DOSE RATE (HDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BRACHYTHERAPY MARKET SIZE, BY LOW-DOSE RATE (LDR) BRACHYTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRACHYTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BRACHYTHERAPY MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BRACHYTHERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. TAIWAN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. THAILAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. VIETNAM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 126. DENMARK BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. EGYPT BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. FINLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FRANCE BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. GERMANY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. ISRAEL BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ITALY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NIGERIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NORWAY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. POLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. QATAR BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. RUSSIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SPAIN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SWEDEN BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. TURKEY BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM BRACHYTHERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. BRACHYTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 232. BRACHYTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. BRACHYTHERAPY MARKET LICENSE & PRICING